Immunoprecise Antibodies (IPA) has a market capitalization of $14.8M, based on 30.73M shares at a price of $0.48 (up 1% today).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
February 2025 | $0.47 | 2,431,892 | 30,732,552 | $14,475,031.99 |
January 2025 | $0.47 | 360,829,670 | 30,732,552 | $14,296,783.19 |
December 2024 | $0.41 | 6,460,949 | 28,132,100 | $11,581,985.57 |
November 2024 | $0.38 | 7,923,215 | 28,132,100 | $10,690,198.00 |
October 2024 | $0.48 | 20,931,437 | 28,132,100 | $13,419,011.70 |
September 2024 | $0.64 | 5,245,365 | 27,132,400 | $17,337,603.60 |
August 2024 | $0.76 | 2,569,191 | 27,132,400 | $20,484,962.00 |
July 2024 | $0.79 | 1,455,881 | 27,132,400 | $21,407,463.60 |
June 2024 | $1.01 | 1,773,568 | 26,944,500 | $27,213,945.00 |
May 2024 | $1.11 | 1,423,429 | 26,944,500 | $29,892,228.30 |
April 2024 | $1.28 | 2,048,302 | 26,944,500 | $34,488,960.00 |
March 2024 | $1.52 | 33,538,378 | 25,050,300 | $38,076,456.00 |
February 2024 | $1.85 | 2,028,485 | 25,050,300 | $46,217,803.50 |
January 2024 | $1.81 | 1,480,478 | 25,050,300 | $45,341,043.00 |
December 2023 | $1.71 | 3,722,377 | 25,050,300 | $42,836,013.00 |
November 2023 | $1.57 | 1,264,130 | 25,050,300 | $39,328,971.00 |
October 2023 | $2.30 | 1,906,329 | 25,050,300 | $57,705,871.08 |
September 2023 | $1.83 | 986,470 | 24,738,800 | $45,272,004.00 |
August 2023 | $1.89 | 1,353,681 | 24,738,800 | $46,756,332.00 |
July 2023 | $2.52 | 532,180 | 24,738,800 | $62,341,776.00 |
June 2023 | $2.96 | 740,273 | 25,030,100 | $74,089,096.00 |
May 2023 | $3.16 | 3,839,802 | 25,030,100 | $79,095,116.00 |
April 2023 | $2.57 | 641,160 | 25,030,100 | $64,327,357.00 |
March 2023 | $2.77 | 1,175,548 | 24,944,700 | $69,096,819.00 |
February 2023 | $4.04 | 860,685 | 24,944,700 | $100,776,588.00 |
